Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 19, 2022

BUY
$3.13 - $8.83 $1,358 - $3,832
434 New
434 $1.44 Million
Q1 2022

May 11, 2022

SELL
$5.87 - $9.46 $2,547 - $4,105
-434 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$7.88 - $18.03 $3,419 - $7,825
-434 Reduced 50.0%
434 $4,000
Q3 2021

Nov 12, 2021

BUY
$10.37 - $30.29 $9,001 - $26,291
868 New
868 $10,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $249M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.